258 related articles for article (PubMed ID: 26110583)
1. APOBEC3 Interference during Replication of Viral Genomes.
Willems L; Gillet NA
Viruses; 2015 Jun; 7(6):2999-3018. PubMed ID: 26110583
[TBL] [Abstract][Full Text] [Related]
2. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
3. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
[TBL] [Abstract][Full Text] [Related]
4. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.
Yoshikawa R; Nakano Y; Yamada E; Izumi T; Misawa N; Koyanagi Y; Sato K
Microbiol Immunol; 2016 Apr; 60(4):272-9. PubMed ID: 26935128
[TBL] [Abstract][Full Text] [Related]
5. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
Poulain F; Lejeune N; Willemart K; Gillet NA
PLoS Pathog; 2020 Aug; 16(8):e1008718. PubMed ID: 32797103
[TBL] [Abstract][Full Text] [Related]
6. Mouse APOBEC3 Restriction of Retroviruses.
Salas-Briceno K; Zhao W; Ross SR
Viruses; 2020 Oct; 12(11):. PubMed ID: 33121095
[TBL] [Abstract][Full Text] [Related]
7. Human APOBEC3 Variations and Viral Infection.
Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
[TBL] [Abstract][Full Text] [Related]
8. Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.
Minkah N; Chavez K; Shah P; Maccarthy T; Chen H; Landau N; Krug LT
Virology; 2014 Apr; 454-455():215-26. PubMed ID: 24725948
[TBL] [Abstract][Full Text] [Related]
9. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
10. Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation.
Delviks-Frankenberry KA; Nikolaitchik OA; Burdick RC; Gorelick RJ; Keele BF; Hu WS; Pathak VK
PLoS Pathog; 2016 May; 12(5):e1005646. PubMed ID: 27186986
[TBL] [Abstract][Full Text] [Related]
11. The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses.
Lovšin N; Gangupam B; Bergant Marušič M
Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535531
[TBL] [Abstract][Full Text] [Related]
12. [Molecular evolution of physiologically functioning anti-retroviral APOBEC3 deaminases].
Miyazawa M
Uirusu; 2012 Jun; 62(1):27-38. PubMed ID: 23189822
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3 proteins and genomic stability: the high cost of a good defense.
Narvaiza I; Landry S; Weitzman MD
Cell Cycle; 2012 Jan; 11(1):33-8. PubMed ID: 22157092
[TBL] [Abstract][Full Text] [Related]
14. APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo.
Renard M; Henry M; Guétard D; Vartanian JP; Wain-Hobson S
J Mol Biol; 2010 Jul; 400(3):323-34. PubMed ID: 20546753
[TBL] [Abstract][Full Text] [Related]
15. [APOBEC3s: history of an antiviral and mutagenic protein family].
Verriez C; Marquet R; Paillart JC; Stupfler B
Virologie (Montrouge); 2020 Dec; 24(6):381-418. PubMed ID: 33441290
[TBL] [Abstract][Full Text] [Related]
16. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.
Simon V; Bloch N; Landau NR
Nat Immunol; 2015 Jun; 16(6):546-53. PubMed ID: 25988886
[TBL] [Abstract][Full Text] [Related]
18. Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.
Monajemi M; Woodworth CF; Benkaroun J; Grant M; Larijani M
Retrovirology; 2012 Apr; 9():35. PubMed ID: 22546055
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs).
de Pablo-Maiso L; Glaria I; Crespo H; Nistal-Villán E; Andrésdóttir V; de Andrés D; Amorena B; Reina R
Viruses; 2017 Nov; 9(11):. PubMed ID: 29149056
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
